Preconditioning and postconditioning reduce hepatic ischemia-reperfusion injury in rats

Hepatobiliary and Pancreatic Diseases International

Volumn 8, Issue 6, 2009, Pages 586-590

  Zhang, Wan Xing ^a   Yin, Wen ^a   Zhang, Lei ^a   Wang, Lan Hui ^a   Bao, Lei ^a   Tuo, Hong Fang ^a   Zhou, Li Fang ^a   Wang, Chun Cheng ^a  

^a Hebei Provincial General Hospital   (China)

Author keywords

Ischemia reperfusion injury; Ischemic postconditioning; Ischemic preconditioning; Liver; NF B

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SUPEROXIDE DISMUTASE; SYNAPTOTAGMIN I;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ISCHEMIC PRECONDITIONING; LIVER ISCHEMIA; LIVER LEVEL; MALE; MICROSCOPY; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; ISCHEMIC PRECONDITIONING; LIVER; MALE; RATS; RATS, WISTAR; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA;

EID: 73849150453     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-588. (Pubitemid 36885888)
2. Nauta RJ, Tsimoyiannis E, Uribe M, Walsh DB, Miller D, Butterfield A. Oxygen-derived free radicals in hepatic ischemia and reperfusion injury in the rat. Surg Gynecol Obstet 1990;171:120-125. (Pubitemid 20286831)
3. Drozdz W, Sarwa A, Labza H. Clinical implication of ischemic preconditioning in protection of reperfused tissues. Przegl Lek 2006;63:271-277.
4. Wang N, Ma QJ, Lu JG, Chu YK, Lai DN. Protective effect of ischemic postconditioning on ischemic reperfusion injury of rat liver graft. Zhonghua Wai Ke Za Zhi 2005;43:1533-1536.
5. Tian XF, Yao JH, Li YH, Gao HF, Wang ZZ, Yang CM, et al. Protective effect of pyrrolidine dithiocarbamate on liver injury induced by intestinal ischemia-reperfusion in rats. Hepatobiliary Pancreat Dis Int 2006;5:90-95.
6. Wheeler MD, Yamashina S, Froh M, Rusyn I, Thurman RG. Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-kappaB activation and cytokine production. J Leukoc Biol 2001;69:622-630. (Pubitemid 32297611)
7. Teoh N, Leclercq I, Pena AD, Farrell G. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 2003;37:118-128.
8. Takahashi Y, Ganster RW, Gambotto A, Shao L, Kaizu T, Wu T, et al. Role of NF-kappaB on liver cold ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2002;283:G1175-1184. (Pubitemid 35192855)
9. Fan C, Li Q, Zhang Y, Liu X, Luo M, Abbott D, et al. IkappaBalpha and IkappaBbeta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation. J Clin Invest 2004;113:746-755. (Pubitemid 38544168)
10. Yoshidome H, Kato A, Edwards MJ, Lentsch AB. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology 1999;30:203-208. (Pubitemid 29300587)
11. Mehvar R. Role of TNF-alpha in liver ischaemia-reperfusion injury: new evidence or experimental artefact? Eur J Clin Invest 2009;39:527-530.
12. Shin T, Kuboki S, Lentsch AB. Roles of nuclear factor-kappaB in postischemic liver. Hepatol Res 2008;38:429-440. (Pubitemid 351593943)
13. Li XC, Ma YF, Wang XH. Role of NF-kappaB as effector of IPC in donor livers before liver transplantation in rats. Transplant Proc 2006;38:1584-1587.
14. Glanemann M, Strenziok R, Kuntze R, Münchow S, Dikopoulos N, Lippek F, et al. Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/reperfusion injury. Surgery 2004;135:203-214. (Pubitemid 38130772)
15. Sileri P, Schena S, Morini S, Rastellini C, Pham S, Benedetti E, et al. Pyruvate inhibits hepatic ischemia-reperfusion injury in rats. Transplantation 2001;72:27-30. (Pubitemid 32652502)
16. Finkel E. The mitochondrion: is it central to apoptosis? Science 2001;292:624-626.
17. Hashimoto K, Nishizaki T, Yoshizumi T, Uchiyama H, Okano S, Ikegami T, et al. Beneficial effect of FR167653 on cold ischemia/reperfusion injury in rat liver transplantation. Transplantation 2000;70:1318-1322. (Pubitemid 30840094)
18. Arab HA, Sasani F, Rafiee MH, Fatemi A, Javaheri A. Histological and biochemical alterations in early-stage lobar ischemia-reperfusion in rat liver. World J Gastroenterol 2009;15:1951-1957.
19. Ozmen MM, Zulfikaroglu B, Col C, Cinel I, Isman FK, Cinel L, et al. Effect of increased abdominal pressure on cytokines (IL1 beta, IL6, TNFalpha), C-reactive protein (CRP), free radicals (NO, MDA), and histology. Surg Laparosc Endosc Percutan Tech 2009;19:142-147.
20. Nishikawa M, Hashida M, Takakura Y. Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. Adv Drug Deliv Rev 2009;61:319-326.
21. Peralta C, Serafin A, Fernández-Zabalegui L, Wu ZY, Roselló-Catafau J. Liver ischemic preconditioning: a new strategy for the prevention of ischemia-reperfusion injury. Transplant Proc 2003;35:1800-1802. (Pubitemid 37093716)
22. Wu BQ, Chu WW, Zhang LY, Wang P, Ma QY, Wang DH. Protection of preconditioning, postconditioning and combined therapy against hepatic ischemia/reperfusion injury. Chin J Traumatol 2007;10:223-227. (Pubitemid 47272479)